The FDAs new indication for semaglutide (Wegovy, Novo Nordisk) comes a little more than 18 months after the medication was initially approved in June 2021 for chronic weight management in adults with obesity or with overweight plus one weight-related condition
The shedding may appear sudden even though the trigger occurred weeks earlier
The sections were incubated overnight in peroxidase-conjugated sheep anti-digoxigenin antibody Fab fragments (Roche, Cat# 11207733910
Please head over to social media!
Renedo D, Acosta J, Leasure A, Sharma R, Krumholz H , de Havenon A, Alahdab F, Aravkin A, Aryan Z, Brnighausen T, Basu S, Burkart K, Coberly K, Criqui M, Dai X, Desai R, Dharmaratne S, Doshi R, Elgendy I, Feigin V, Filip I, Gad M, Ghozy S, Hafezi-Nejad N, Kalani R, Karaye I, Kisa A, Krishnamoorthy V, Lo W, Mestrovic T, Miller T, Misganaw A, Mokdad A, Murray C, Natto Z, Radfar A, Ram P, Roth G, Seylani A, Shah N, Sharma P, Sheikh A, Singh J, Song S, Sotoudeh H, Vervoort D, Wang C, Xiao H, Xu S, Zand R, Falcone G, Sheth K
